Month: October 2026

Atlanta, GA, Oct. 26, 2026 (GLOBE NEWSWIRE) — Piedmont Realty Trust (NYSE: PDM) has released its financial and operational results for the third quarter of 2026.  Please visit the Investor Relations section of Piedmont’s website at https://investor.piedmontreit.com to access the Earnings Release and Supplemental Information.

Piedmont has scheduled a conference call and an audio web cast for Tuesday, October 27, 2026, at 9:00 a.m. ET during which the Company’s management team will review third quarter performance, discuss recent events, and conduct a question-and-answer period.

To Listen to the Live or Replay of the Webcast:
Click on the webcast link under the Investor Relations section of the Company’s website at https://investor.piedmontreit.com/news-and-events/event-calendar

For analysts that are participating in the Conference Call:
Please dial in at least fifteen minutes prior to start time to ensure a timely connection.
Domestic: (888) 506-0062
International: (973) 528-0011
Participant Access Code: 836460

To Listen to the Replay Telephonically:
Domestic: (877) 481-4010
International: (919) 882-2331
Replay Passcode: 54602

The playback can be accessed through November 10, 2026.

About Piedmont Realty Trust

Piedmont Realty Trust™ (NYSE: PDM), is a fully integrated, self-managed real estate investment company focused on delivering an exceptional office environment. As an owner, manager, developer and operator of approximately 16 MM SF of Class A properties across major U.S. Sunbelt markets, Piedmont Realty Trust is known for its hospitality-driven approach and commitment to transforming buildings into premier “Piedmont PLACEs” that enhance each client’s workplace experience.

Research Analysts/ Institutional Investors Contact:
770-418-8592
investor.relations@piedmontreit.com

Shareholder Services/Transfer Agent Services Contact:
Computershare, Inc.
866-354-3485
investor.services@piedmontreit.com

WEST PALM BEACH, Fla., Oct. 26, 2026 (GLOBE NEWSWIRE) — LXP Industrial Trust (NYSE: LXP) (“LXP” or “the Company”) today announced that its shareholders approved the acquisition of LXP by Brookfield Asset Management (NYSE: BAM, TSX: BAM) and Canada Pension Plan Investment Board at the Special Meeting of Shareholders held earlier today.

According to the results of the Special Meeting of Shareholders, more than 99% of votes cast at the meeting – which represented approximately 82% of the outstanding LXP common shares as of the record date – were voted in favor of approving the merger. The final voting results of the Special Meeting of Shareholders will be filed as part of LXP’s Form 10-Q for the quarter ended September 30, 2026 with the U.S. Securities and Exchange Commission (the “SEC”) after certification by LXP’s inspector of election.

Under the terms of the merger agreement announced on July 20, 2026, common shareholders of the Company will receive $61.20 in cash for each LXP common share owned. The transaction is expected to be completed on November 2, 2026, subject to the satisfaction or waiver of the conditions to the closing of the transaction in the merger agreement. Upon closing of the transaction, LXP’s shares will no longer be listed on the New York Stock Exchange or any other public market.

About LXP Industrial Trust
LXP Industrial Trust (NYSE: LXP) is a publicly traded real estate investment trust (REIT) focused on Class A warehouse and distribution investments in 12 target markets across the Sunbelt and Midwest. LXP seeks to expand its warehouse and distribution portfolio through acquisitions, build-to-suit transactions, sale-leaseback transactions, development projects and other transactions. For more information, please visit LXP’s website at www.lxp.com.

Forward-Looking Statements
Certain statements contained herein, other than historical fact, regarding the proposed transaction, including any statements regarding the expected timetable for completing the proposed transaction and benefits of the proposed transaction, and any other statements regarding the Company’s future expectations, beliefs, plans, objectives, financial conditions, assumptions or future events or performance that are not historical, may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbor provided by the same. These statements are based on management’s current expectations and beliefs and are subject to a number of trends and uncertainties. No forward-looking statement is intended to, nor shall it, serve as a guarantee of future performance. You can identify the forward-looking statements by the use of words such as “may,” “will,” “would,” “could,” “should,” “expect,” “intend,” “anticipate,” “estimate,” “believe,” “continue,” “seek,” “endeavor,” and other similar terms and phrases. Forward-looking statements are subject to various risks and uncertainties and factors that could cause actual results to differ materially from the Company’s expectations, and you should not rely on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company’s control and could materially affect the Company’s results of operations, financial condition, cash flows, performance or future achievements or events. Some of the factors that may affect outcomes and results include, but are not limited to: (i) risks associated with the Company’s ability to consummate the proposed transaction and the timing of the closing of the proposed transaction, including the risks that a condition to closing would not be satisfied within the expected timeframe or at all or that the closing of the proposed transaction would not occur, (ii) the outcome of any legal proceedings that may be instituted against the parties and others related to the merger agreement and the costs related to such proceedings, and (iii) the risk that shareholder litigation or other proceedings in connection with the proposed transaction may affect the timing or occurrence of the proposed transaction or result in significant costs of defense, indemnification and liability, and (iv) the risk that the Company’s stock price may decline significantly if the proposed transaction is not consummated. Additional factors include those described under the section entitled Item 1A. “Risk Factors” of the Company’s 2025 Annual Report on Form 10-K, as filed with the SEC on February 25, 2026, and the Company’s most recent Form 10-Q, as filed with the SEC on July 29, 2026, copies of which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law.

Contact:
Investor or Media Inquiries for LXP Industrial Trust:
Heather Gentry, Executive Vice President of Investor Relations
LXP Industrial Trust
Phone: (212) 692-7200 E-mail: hgentry@lxp.com

KANSAS CITY, Mo., Oct. 26, 2026 (GLOBE NEWSWIRE) — H&R Block, Inc. (NYSE: HRB) will report fiscal 2027 first quarter results on Monday, November 9, 2026, after the New York Stock Exchange market close. At that time, a copy of the press release and presentation will be available on the company’s investor relations website at https://investors.hrblock.com/.

A conference call for analysts, institutional investors, and shareholders will be held at 4:30 p.m. Eastern time on Monday, November 9, 2026. During the conference call the company will discuss fiscal 2027 first quarter results, outlook, and give a general business update. To join live, participants must register at https://register-conf.media-server.com/register/BI46c1c99bcb2d4f8a8a49d697da287d8d. Once registered, the participant will receive a dial-in number and unique PIN to access the call. Please join approximately 5 minutes prior to the scheduled start time.

The call, along with a presentation for viewing, will also be webcast in a listen-only format for the media and public. The webcast can be accessed directly at https://edge.media-server.com/mmc/p/b3k2w7ce/lan/en and will be available for replay 2 hours after the call is concluded and continuing for 90 days.

About H&R Block
H&R Block, Inc. (NYSE: HRB) provides help and inspires confidence in its clients and communities everywhere through global tax preparation services, financial products, and small business solutions. Named CNET’s Best Overall online tax service for 2026, the company blends digital innovation with human expertise and care as it helps people get the best outcome at tax time and manage their money better using its mobile banking app, Spruce. Through Block Advisors and Wave, the company helps small-business owners thrive with year-round bookkeeping, payroll, advisory, and payment processing solutions. For more information, visit H&R Block News.

CONTACT: For Further Information

Investor Relations:
Jessica Hazel, (816) 854-4214, jessica.hazel@hrblock.com

Media Relations:
Media Desk, mediadesk@hrblock.com

CHICAGO, Oct. 26, 2026 (GLOBE NEWSWIRE) — FreightCar America, Inc. (NASDAQ: RAIL), a diversified manufacturer of railroad freight cars, today announced that it will release its third quarter 2026 financial results on Monday, November 9, 2026, after the market close, and host a teleconference to discuss its third quarter 2026 results on the following day. Teleconference details are as follows:

• Tuesday, November 10, 2026
• 11:00 a.m. Eastern Time
• Phone: 1-877-407-0789 or 1-201-689-8562
• Webcast access: https://viavid.webcasts.com/starthere.jsp?ei=1778357&tp_key=a788b0726f

Please note that the webcast is listen-only and webcast participants will not be able to participate in the question and answer portion of the conference call. Interested parties are asked to dial in approximately 10 to 15 minutes prior to the start time of the call.

An audio replay of the conference call will be available beginning at 3:00 p.m. (Eastern Time) on Tuesday, November 10, 2026, until 11:59 p.m. (Eastern Time) on Tuesday, November 24, 2026. To access the replay, please dial (844) 512-2921 or (412) 317-6671. The replay passcode is 13763137. An archived version of the webcast will also be available on the FreightCar America Investor Relations website.

About FreightCar America

FreightCar America, headquartered in Chicago, Illinois, is a leading designer, producer and supplier of railroad freight cars, railcar parts and components. We also specialize in railcar repairs, complete railcar rebody services and railcar conversions that repurpose idled rail assets back into revenue service. Since 1901, our customers have trusted us to build quality railcars that are critical to economic growth and instrumental to the North American supply chain. To learn more about FreightCar America, visit www.freightcaramerica.com.

Investor Contact:	chris@jbgcapadvisory.com

Net revenue rose 23% to $1.39 million with gross margin expanding to 40.2%, driven by B2B distribution growth and reduction in purchase costs compared with last period due to establishment of stable relationships with suppliers from 2026, which enabled SL Science Holding Limited to obtain favorable procurement terms.

Taipei, TAIWAN, Oct. 26, 2026 (GLOBE NEWSWIRE) — SL Science Holding Limited (“SL Science” or the “Company”) (NASDAQ: SLBT), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced its unaudited financial results for the six months ended June 30, 2026.

Management Commentary

“The first half of 2026 marked a period of profound structural execution and milestone achievement for SL Science. We successfully closed our business combination on June 12, and listed on the Nasdaq Global Market on June 15, supported by a concurrent $7.8 million PIPE financing. This capitalization provides the foundational strength required to advance our clinical programs. Concurrently, our deliberate pivot from direct retail to a B2B wholesale distribution model in Taiwan yielded immediate results. We drove a 23% increase in top-line revenue and expanded our gross margin to over 40% through enhanced volume predictability and optimized supplier pricing agreements,” said Mr. William Wang, Chief Executive Officer of SL Science.

“Our strategic focus remains squarely on advancing our core oncology assets. We continuously increased research and development investments by 72% over the prior year, directing critical resources toward preclinical scale-up and regulatory preparedness for both our CD-19 Armed-T and Gamma Delta T (GDT) cell therapy platforms. By securing 20-year global exclusive rights for GDT cell applications in pancreatic and brain cancers and successfully completing key manufacturing and institutional review board (IRB) preparatory milestones with HeXun Biosciences, we are systematically de-risking our pathway to the clinic. Our vision is to establish SL Science as a global clinical leader, addressing severe unmet medical needs through breakthrough, scalable cellular innovations,” Mr. Wang added.

SL Science’s First Half 2026 Financial Results

SL Bio is primarily engaged in sales of plant extract products and milk-derived exosome products to customers in Taiwan, while advancing its research and development in the biomedical industry, including with CD-19 Armed-T products and GDT cell therapy products for brain and pancreatic cancers. The following table presents selected summarized financial information derived from the Company’s consolidated statements of operations for the six months ended June 30, 2026 and 2025:

In thousands USD, except percentage data, differences due to rounding	For the six months ended June 30, 2026		For the six months ended June 30, 2025		Variance %
Net Revenue	1,387		1,129		23	%
Cost of Revenue	(829	)	(740	)	12	%
Gross Profit	558		389		43	%
General and Administrative Expenses	1,490		1,282		16	%
Research and Development Expenses	1,230		717		72	%
Total Operating Expenses	2,720		1,999		36	%
Loss from Operations	(2,162	)	(1,610	)	34	%
Net Loss	(2,162	)	(1,602	)	35	%

Net Revenue

Net revenue increased by approximately $0.26 million, or 22.8%, to approximately $1.39 million for the six months ended June 30, 2026, compared to approximately $1.13 million for the six months ended June 30, 2025. The increase was primarily attributable to the continued ramp-up of SL Bio Taiwan’s wholesale distribution model following the business transformation initiated in the third quarter of 2024, shifting from direct sales to individual end-users toward corporate distributors. Established distributor relationships and larger, more predictable business-to-business order volumes drove higher shipment levels, offsetting the lower per-unit pricing associated with wholesale transactions.

Cost of Revenue

Cost of revenue increased by approximately $0.09 million, or 12.0%, to approximately $0.83 million for the six months ended June 30, 2026, compared to approximately $0.74 million for the six months ended June 30, 2025. Cost of revenue consists primarily of purchase costs on products for resales, increasing in line with higher sales volume.

Gross Profit

Gross profit increased by 43.3% to approximately $0.56 million for the six months ended June 30, 2026, compared to approximately $0.39 million for the prior year period. Our gross profit margin improved to 40.2% from 34.5%, mainly driven by the reduction in purchase costs due to the establishment of stable relationships with suppliers, enabling favorable procurement terms.

Operating Expenses

Total operating expenses increased by approximately $0.72 million, or 36.1%, to approximately $2.72 million for the six months ended June 30, 2026, compared to approximately $2.00 million for the six months ended June 30, 2025. The increase was primarily driven by a 16.2% expansion in general and administrative expenses due to a 13.6% increase in office salaries from management team expansion and a 33.2% increase in professional service fees incurred during the listing process.

Research and development expenses increased by 71.5% to approximately $1.23 million for the six months ended June 30, 2026, from $0.72 million in the prior year period. This was mainly due to increased salaries for R&D staff and milestone payments based on the progress of CD-19 Armed-T products and GDT cell therapy products.

Net Loss

Net loss for the six months ended June 30, 2026 was approximately $2.16 million, compared to a net loss of approximately $1.60 million for the six months ended June 30, 2025.

Cash and Cash Equivalents

As of June 30, 2026, SL Science’s cash and cash equivalents stood at approximately $8.31 million compared to approximately $1.26 million as of December 31, 2025. The increase was driven primarily by net cash generated from financing activities of approximately $9.15 million, netted off with the net cash used in operating activities of approximately $2.09 million. Working capital stood at approximately $6.67 million.

SL Science Major Developments and Outlook

Gamma Delta T (GDT) Cell Therapy Platform

• Strategic Licensing & Milestones: Secured global exclusive rights from JY BioMed for GDT cell applications in pancreatic and brain cancers for a term of 20 years following product launch. The Company previously paid $1.0 million for initial R&D under its GDT licensing agreement and recognized $825,000 in expenses in H1 2026 after HeXun Biosciences successfully completed IRB specimen preparation and quality documentation milestones.
• FDA Regulatory Submissions: Advanced its regulatory footprint by submitting an Orphan Drug Designation (ODD) request (DRU-2026-11528) to the U.S. FDA for its GDT cell therapy targeting glioblastoma. The Company also filed Drug Master Files (DMF) for both its GDT cells and GDT cell-derived exosomes, establishing a standardized manufacturing foundation for future commercialization.
• Preclinical Validation: Demonstrated the platform’s efficacy through multiple global presentations. In July 2026, SL Science exhibited data at the World Congress of Basic and Clinical Pharmacology showing potent destruction of brain cancer cells in preclinical models. In September 2026, data presented at the 85^th Annual Meeting of the Japanese Cancer Association revealed that these GDT cells directly target and eliminate chemotherapy-resistant glioblastoma cells.
• Clinical Framework: Leadership co-authored a peer-reviewed framework in Biomedicines with Taipei Medical University, defining rigorous clinical development standards for GDT therapies in glioblastoma.

CD-19 Armed-T Therapy

• The Company holds a perpetual, exclusive global license from CytoArm Co., Ltd. for CD-19 Armed-T products. Following an initial payment of $277,200, SL Science is positioned to complete up to NTD 133 million (~$4.10 million) in milestone payments to advance this blood cancer therapy through clinical development.

Recent Corporate Milestones

• Nasdaq Listing: Closed its business combination on June 12, 2026, with ordinary shares commencing trading under the ticker “SLBT” on June 15, 2026. Leadership rang the Nasdaq closing bell on September 2, 2026, to celebrate its first quarter as a public company.
• Capital Formation: Secured a concurrent $7.8 million PIPE financing alongside the listing to accelerate growth and operational capabilities.
• Share Incentive Plan: Approved the 2026 Share Incentive Plan to attract and retain top talent, authorizing up to 85,000,000 ordinary shares for awards.

About SL Science Holding Limited

SL Science Holding Limited is a biomedical company specializing in developing innovative cellular and gene therapies. Established with a commitment to advancing regenerative medicine and cancer treatment, the Company hopes to utilize immune cell technologies to target cancer, thus potentially offering expansive medical applications for its products. With technologies such as Gamma Delta T cells targeting solid tumor indications including pancreatic and brain cancers, SL Science aims to create cellular therapies that the Company believes have the potential to advance the cell therapy and immuno-oncology sector within the broader biopharmaceutical industry. For more information, please visit the Company’s website at: https://www.slbtgroup.com/ and follow SLBT on X, LinkedIn, FB, IG and Threads.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of the federal securities laws with respect to the business of SL Science. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. The data described above are preclinical and do not establish the clinical safety or efficacy of any product; preclinical results are frequently not predictive of clinical outcomes. Many factors could cause actual future events to differ materially, including the ability to implement the Company’s business plans and clinical trials; to obtain and maintain regulatory approvals and rights under its license arrangements; the potential for its products to reach commercialization; and the Company’s need for additional capital. The Company assumes no obligation to update these forward-looking statements, except as required by applicable law.

Contact Details:

SL Science Holding Limited
Tel: +886-2-26516826
Email: ir@slbtgroup.com

WFS Investor Relations Inc.
Email: services@wfsir.com
+1 628 283 9214

SL SCIENCE HOLDING LIMITED AND SUBSIDIARIES
INTERIM CONSOLIDATED BALANCE SHEETS
AS OF JUNE 30, 2026 (UNAUDITED) AND DECEMBER 31, 2025

		June 30, 2026				December 31, 2025
			(Unaudited)
ASSETS
CURRENT ASSETS
Cash and cash equivalents		$	8,306,692			$	1,258,616
Inventories			73,267				–
Prepaid expenses and other current assets			234,340				167,612
Tax recoverable			–				597
TOTAL CURRENT ASSETS			8,614,299				1,426,825
Operating lease right-of-use assets, net			136,913				212,324
Plant and equipment, net			159,926				248,894
Deferred offering costs			–				929,137
TOTAL ASSETS		$	8,911,138			$	2,817,180
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Operating lease liabilities, current		$	137,598				148,663
Accrued expenses and other liabilities			202,850				319,872
Due to Director			1,600,000				–
TOTAL CURRENT LIABILITIES			1,940,448				468,535
Operating lease liabilities, non-current			–				64,742
TOTAL LIABILITIES			1,940,448				533,277
Ordinary shares, $0.00001 par value; 4,950,000,000 shares authorized, 560,759,740 and 556,800,001 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively*		$	5,608			$	5,568
Series A preferred shares, $0.00001 par value, 50,000,000 shares authorized, 780,000 shares issued and outstanding as of June 30, 2026			8				–
Additional paid-in-capital			14,157,893				7,293,276
Accumulated deficits			(7,646,583	)			(5,484,378	)
Accumulated other comprehensive income			453,764				469,437
Total shareholders’ equity			6,970,690				2,283,903
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY		$	8,911,138			$	2,817,180

SL SCIENCE HOLDING LIMITED AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS AND
COMPREHENSIVE INCOME (LOSS)

		For the Six Months Ended June 30,
		2026				2025
Revenue		$	1,386,608			$	1,129,238
Cost of revenue			(829,124	)			(740,172	)
Gross profit			557,484				389,066
Operating expenses
General and administrative expenses			1,489,663				1,281,786
Research and development expenses			1,229,998				268,451
Research and development expenses – related party			–				448,571
Total operating expenses			2,719,661				1,998,808
Loss from operations			(2,162,177	)			(1,609,742	)
Other income (expenses)
Other (expenses) income, net			(7,549	)			(21,358	)
Interest income			7,521				29,007
Total other income (expenses), net			(28	)			7,649
Loss before income tax			(2,162,205	)			(1,602,093	)
Income tax credit (expense)			–				4
Net loss		$	(2,162,205	)		$	(1,602,089	)
Other comprehensive loss, net of tax:
Change in cumulative foreign currency translation			(15,673	)			469,815
Comprehensive loss		$	(2,177,878	)		$	(1,132,274	)
Basic net (loss) income per share*			(0.00	)			(0.00	)
Basic weighted average number of shares outstanding*			557,215,664				556,800,001
Diluted net (loss) income per share*			(0.00	)			(0.00	)
Diluted weighted average number of shares outstanding*			557,215,664				556,800,001

SL SCIENCE HOLDING LIMITED AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE SIX MONTHS ENDED JUNE 30, 2026 AND 2025

						For the Six Months
						Ended June 30,
		Note				2026				2025
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss						$	(2,162,205	)		$	(1,602,089	)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation expenses			5				84,838				5,937
Lease expenses			6				—				76,627
Changes in operating assets and liabilities
Inventories							(73,267	)			650,498
Prepaid expenses and other current assets							175,773				195,674
Accrued expenses and other liabilities							(117,022	)			167,346
Deferred tax liabilities							—				(4,390	)
Amount due to an affiliate							—				444,477
Operating lease liabilities							(396	)			(68,237	)
Tax refund							597				—
Net cash (used in) operating activities							(2,091,682	)			(134,157	)
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisition of plant and equipment			5				—				(317,676	)
Net cash (used in) investing activities							—				(317,676	)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Director							1,600,000				—
Proceeds from reverse recapitalization							155,574				—
Proceeds from PIPE units							7,800,000				—
Payment of offering cost related to reverse recapitalization							(404,273	)			(614,373	)
Net cash provided by (used in) financing activities							9,151,301				(614,373	)
Effect of change in exchange rate							(11,543	)			473,972
NET INCREASE / (DECREASE) IN CASH AND CASH EQUIVALENTS							7,048,076				(592,234	)
Cash and cash equivalents, beginning of year							1,258,616				4,137,526
Cash and cash equivalents, end of year						$	8,306,692			$	3,545,292
SUPPLEMENTAL CASH FLOW INFORMATION:
Income taxes paid						$	—			$	—
Interest paid						$	—			$	—
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTMENT AND FINANCIAL ACTIVITIES INFORMATION:
Addition to operating lease right-of-use assets and lease liabilities						$	—			$	344,702
Reclassification of deferred offering costs to additional paid-in capital upon business combination						$	1,333,410			$	—
Assets acquired from reverse recapitalization						$	242,501			$	—
Liabilities assumed from reverse recapitalization (settled by working capital loan)						$	1,001,134			$	—

HAMILTON, BERMUDA, October 26, 2026 – DHT Holdings, Inc. (NYSE: DHT or the “Company”) will release its third quarter 2026 results after market close on Monday, November 9, 2026.

The Company will host a conference call and webcast, which will include a slide presentation, at 8:00 a.m. EST/14:00 CET on Tuesday, November 10, 2026, to discuss the results for the quarter.

To access the conference call the participants are required to register in advance of the conference using this link:  
https://register-conf.media-server.com/register/BI19dc075163194806919c470d0234919f

Upon registering, each participant will be provided with participant dial-in numbers and a unique personal PIN. Participants will need to use the conference access information provided in the e-mail received at the point of registering. Participants may also use the Call Me feature instead of dialing the nearest dial-in number.

The webcast, which will include a slide presentation, will be available on the following link:
https://edge.media-server.com/mmc/p/5zaim64v and can also be accessed in the Investor Relations section on DHT’s website at www.dhtankers.com.

A recording of the audio and slides presented will be available until November 17, 2026, at 14:00 CET.

The recording can be accessed through the following link:
https://edge.media-server.com/mmc/p/5zaim64v

About DHT Holdings, Inc.
DHT is an independent crude oil tanker company. Our fleet trades internationally and consists of crude oil tankers in the VLCC segment. We operate through our wholly owned management companies in Monaco, Norway, Singapore, and India. You may recognize us by our renowned business approach as an experienced organization with focus on first rate operations and customer service; our quality ships; our prudent capital structure that promotes staying power through the business cycles; our fleet employment with a combination of market exposure and fixed income contracts; our disciplined capital allocation strategy through cash dividends, investment in vessels, debt prepayments and share buybacks; and our transparent corporate structure maintaining a high level of integrity and corporate governance. For further information please visit www.dhtankers.com.

Contact:
Laila C. Halvorsen, CFO
Phone: +1 441 295 1422 and +47 984 39 935
E-mail: lch@dhtankers.com

LONDON and GAITHERSBURG, Md., Oct. 26, 2026 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a commercial stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, today announced that the Company will release its third quarter 2026 financial results and operational highlights before open of U.S. markets on Tuesday, November 10, 2026.

Management will host a conference call and webcast at 8:30am EST / 1:30pm GMT to discuss the Company’s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call.

A simultaneous audio webcast and replay will be accessible on the events section of Autolus’ website.

About Autolus Therapeutics plc
Autolus Therapeutics plc (Nasdaq: AUTL) is a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation T cell therapies and candidates for the treatment of cancer and autoimmune disease. Using a broad suite of proprietary and modular T cell programming technologies, Autolus is engineering precisely targeted and controlled T cell therapies that are designed to better recognize target cells, break down their defense mechanisms and eliminate these cells. Autolus has a marketed therapy and a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. For more information, please visit www.autolus.com.

Contact:

Amanda Cray 
+1 617-967-0207 
a.cray@autolus.com 

WEST PALM BEACH, Fla., Oct. 26, 2026 (GLOBE NEWSWIRE) — Onity Group Inc. (NYSE: ONIT) (“Onity” or the “Company”) today announced that it will hold a conference call on Thursday, November 5, 2026 at 8:30 a.m. (ET) to review the Company’s third quarter 2026 operating results and provide a business update.

All interested parties are welcome to participate. You can access the conference call by dialing (833) 309-3473 or (785) 838-9251 approximately 10 minutes prior to the call; please reference the conference ID “Onity.” Participants can also access the conference call through a live audio webcast available from the Shareholder Relations page at onitygroup.com under Events and Presentations.

An investor presentation will accompany the conference call and be available by visiting the Shareholder Relations page at onitygroup.com prior to the call.

A replay of the conference call will be available via the website approximately two hours after the conclusion of the call. A telephonic replay will also be available approximately three hours following the call’s completion through November 19, 2026, by dialing (844) 512-2921 or (412) 317-6671; please reference access code 11162788.

About Onity Group

Onity Group Inc. (NYSE: ONIT) is a leading non-bank financial services company delivering mortgage servicing and originations solutions through Onity Mortgage Corporation. As one of the largest mortgage servicers in the country, we help consumers and business clients achieve their homeownership and financial goals with a wide range of servicing and lending programs powered by a technology-enabled, customer-centric platform. Headquartered in West Palm Beach, Florida, with offices and operations in the United States, the U.S. Virgin Islands, India and the Philippines, we have been serving our customers since 1988. For additional information, please visit onitygroup.com or onitymortgage.com.

For Further Information Contact:

Investors:
Valerie Haertel, VP, Investor Relations
(561) 570-2969
shareholderrelations@onitygroup.com

Media:
Dico Akseraylian, SVP, Corporate Communications
(856) 917-0066
mediarelations@onitygroup.com

NORTON, Mass., Oct. 26, 2026 (GLOBE NEWSWIRE) — CPS Technologies Corp. (Nasdaq:CPSH) today released instructions for its third quarter 2026 investor conference call which will be held on Wednesday November 4, 2026 at 9:00 A.M. (Eastern). Brian Mackey, President and CEO and Chris Fraser, Chief Financial Officer will discuss the Company’s financial results for the quarter ended September 26, 2026.

Those interested in participating in the conference call should dial:

1-844-943-2942
Participant Passcode: 258164

About CPS

CPS is an advanced materials company that designs, manufactures, and sells high-performance material solutions to global customers in transportation, energy, automotive, electronics, telecommunications, aerospace, and defense. The company specializes in proprietary metal matrix composites (MMCs), combining metals and ceramics to deliver superior strength, thermal management, and reliability for demanding applications such as high-speed rail, HVDC systems, mass transit, electric vehicles, internet equipment, and electrical infrastructure. CPS also produces hermetic packaging for high-reliability power and communications modules, supporting avionics, GPS, microprocessors, and specialized integrated circuits. Additionally, its lightweight HybridTech Armor® provides high strength-to-weight protection. CPS focuses on innovation, quality, and diversified high-growth markets to drive sustained, profitable growth. The Company’s Vision is “to pioneer the next generation of high-performance materials and solve the world’s toughest engineering challenges.”

CPS Technologies Corporation
111 South Worcester Street
Norton, MA 02766
www.cpstechnologysolutions.com

Investor Relations:
Chris Witty
646-438-9385
cwitty@darrowir.com

NEWARK, Ohio, Oct. 26, 2026 (GLOBE NEWSWIRE) — Park National Corporation (Park) (NYSE American: PRK) today reported financial results for the third quarter and the first nine months of 2026. Park’s board of directors declared a quarterly cash dividend of $1.10 per common share and a special cash dividend of $1.30 per common share, payable on December 10, 2026, to common shareholders of record as of November 20, 2026.

Park’s net income for the third quarter of 2026 was $56.9 million, a 20.7 percent increase from $47.2 million for the third quarter of 2025. The third quarter of 2026 included $7.0 million ($5.5 million after tax) in expenses related to the merger with First Citizens Bancshares, Inc. Third quarter 2026 net income per diluted common share was $3.13, compared to $2.92 for the third quarter of 2025. Park’s net income for the first nine months of 2026 was $157.4 million, a 14.5 percent increase from $137.4 million for the first nine months of 2025. The first nine months of 2026 included $26.5 million ($21.0 million after tax) in merger-related expenses and other income reducing charges. Net income per diluted common share for the first nine months of 2026 was $8.77, compared to $8.48 for the first nine months of 2025.

“Our continued solid financial performance reflects the strength of our relationship-based approach to banking and the dedication of our colleagues who work every day to help things go right for our stakeholders,” said Park CEO and president Matthew R. Miller. “We are grateful for the trust our customers and communities place in us, including the communities we have recently welcomed in Tennessee.

“We are once again pleased to recognize the commitment of our shareholders with a special dividend payable in December. Their continued support enables us to advance our mission of helping those we serve achieve financial success and prosperity.”

Park’s total loans increased $1.72 billion, or 21.4 percent, during 2026. The increase to total loans included $1.58 billion in loans acquired through the First Citizens transaction. Park’s total deposits increased $2.38 billion, or 28.9 percent, during 2026, with an increase of 27.3 percent including off balance sheet deposits. The increase in total deposits included $2.22 billion in deposits acquired through the First Citizens transaction. The combination of solid loan growth and steady deposits contributed to Park’s success in 2026.

“Our results represent the compounded effect of our colleagues’ best efforts every day,” said Park Chairman David L. Trautman. “From our newest team members to those who have dedicated more than 45 years to Park, our people pour themselves into serving others, trusting that if we do the right things consistently, the results will follow. So far this year, the scoreboard looks favorable.”

Headquartered in Newark, Ohio, Park National Corporation has $12.6 billion in total assets (as of September 30, 2026). Park’s banking operations are conducted through its subsidiary, The Park National Bank. Other Park subsidiaries are Scope Leasing, Inc. (d.b.a. Scope Aircraft Finance), Park Investments, Inc., Park National Holdings, Inc., First Citizens Properties, Inc., First Citizens Risk Management, Inc., and SE Property Holdings, LLC.

Complete financial tables are listed below.

Category: Earnings

Media contact: Michelle Hamilton, 740.349.6014, media@parknationalbank.com

Investor contact: Brady Burt, 740.322.6844, investor@parknationalbank.com

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Park cautions that any forward-looking statements contained in this news release or made by management of Park are provided to assist in the understanding of anticipated future financial performance. Forward-looking statements provide current expectations or forecasts of future events and are not guarantees of future performance. The forward-looking statements are based on management’s expectations and are subject to a number of risks and uncertainties, including those described in Park’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as updated by our filings with the SEC. Although management believes that the expectations reflected in such forward-looking statements are reasonable, actual results may differ materially from those expressed or implied in such statements.

Risks and uncertainties that could cause actual results to differ include, without limitation: (1) the ability to execute our business plan successfully and manage strategic initiatives; (2) the impact of current and future economic and financial market conditions, including unemployment rates, inflation, interest rates, supply-demand imbalances, and geopolitical matters; (3) factors impacting the performance of our loan portfolio, including real estate values, financial health of borrowers, and loan concentrations; (4) the effects of monetary and fiscal policies, including interest rates, money supply, and inflation; (5) changes in federal, state, or local tax laws; (6) the impact of changes in governmental policy and regulatory requirements on our operations; (7) changes in consumer spending, borrowing, and saving habits; (8) changes in the performance and creditworthiness of customers, suppliers, and counterparties; (9) increased credit risk and higher credit losses due to loan concentrations; (10) volatility in mortgage banking income due to interest rates and demand; (11) adequacy of our internal controls and risk management programs; (12) competitive pressures among financial services organizations; (13) uncertainty regarding changes in banking regulations and other regulatory requirements; (14) our ability to meet heightened supervisory requirements and expectations; (15) the impact of changes in accounting policies and practices on our financial condition; (16) the reliability and accuracy of assumptions and estimates used in applying critical accounting estimates; (17) the potential for higher future credit losses due to changes in economic assumptions; (18) the ability to anticipate and respond to technological changes and our reliance on third-party vendors; (19) operational issues related to and capital spending necessitated by the implementation of information technology systems on which we are highly dependent; (20) the ability to secure confidential information and deliver products and services through computer systems and telecommunications networks; (21) the impact of security breaches or failures in operational systems; (22) the impact of geopolitical instability and trade policies on our operations including the imposition of tariffs and retaliatory tariffs; (23) the impact of changes in credit ratings of government debt and financial stability of sovereign governments; (24) the effect of stock market price fluctuations on our asset and wealth management businesses; (25) litigation and regulatory compliance exposure; (26) availability of earnings and excess capital for dividend declarations; (27) the impact of fraud, scams, and schemes on our business; (28) the impact of natural disasters, pandemics, and other emergencies on our operations; (29) potential deterioration of the economy due to financial, political, or other shocks; (30) impact of healthcare laws and potential changes on our costs and operations; (31) the ability to grow deposits and maintain adequate deposit levels, including by mitigating the effect of unexpected deposit outflows on our financial condition; (32) risks related to the completed acquisition of First Citizens, including the possibility that anticipated benefits are not realized as expected, including the realization of anticipated cost savings and revenue generation, difficulties integrating the two companies, and potential adverse reactions to customer, business, or employee relationships; and (33) other risk factors related to the banking industry.

Park does not undertake, and specifically disclaims any obligation, to publicly release the results of any revisions that may be made to update any forward-looking statement to reflect the events or circumstances after the date on which the forward-looking statement was made, or reflect the occurrence of unanticipated events, except to the extent required by law.

PARK NATIONAL CORPORATION
Financial Highlights
As of or for the three months ended September 30, 2026, June 30, 2026 and September 30, 2025
		2026			2026			2025			Percent change 3Q ’26 vs.
(in thousands, except common share and per common share data and ratios)	3rd QTR			2nd QTR			3rd QTR				2Q ’26		3Q ’25
INCOME STATEMENT:
Net interest income	$	140,743		$	138,857		$	111,017			1.4	%	26.8	%
(Recovery of) provision for credit losses		(964	)		4,575			4,030			(121.1)	%	(123.9)	%
Other income		36,638			39,540			30,574			(7.3)	%	19.8	%
Other expense		107,544			100,960			79,463			6.5	%	35.3	%
Income before income taxes	$	70,801		$	72,862		$	58,098			(2.8)	%	21.9	%
Income taxes		13,869			14,110			10,940			(1.7)	%	26.8	%
Net income	$	56,932		$	58,752		$	47,158			(3.1)	%	20.7	%
MARKET DATA:
Earnings per common share – basic (a)	$	3.15		$	3.25		$	2.93			(3.1)	%	7.5	%
Earnings per common share – diluted (a)		3.13			3.23			2.92			(3.1)	%	7.2	%
Quarterly cash dividend declared per common share		1.10			1.10			1.07			—	%	2.8	%
Book value per common share at period end		94.83			95.58			82.87			(0.8)	%	14.4	%
Market price per common share at period end		178.66			182.99			162.53			(2.4)	%	9.9	%
Market capitalization at period end		3,227,343			3,305,561			2,612,076			(2.4)	%	23.6	%
Weighted average common shares – basic (b)		18,064,161			18,085,919			16,071,347			(0.1)	%	12.4	%
Weighted average common shares – diluted (b)		18,182,939			18,181,868			16,173,271			—	%	12.4	%
Common shares outstanding at period end		18,064,161			18,064,161			16,071,347			—	%	12.4	%
PERFORMANCE RATIOS: (annualized)
Return on average assets (a)(b)		1.77	%		1.84	%		1.83	%		(3.8)	%	(3.3)	%
Return on average shareholders’ equity (a)(b)		12.92	%		13.69	%		14.19	%		(5.6)	%	(8.9)	%
Yield on loans		6.42	%		6.42	%		6.34	%		—	%	1.3	%
Yield on investment securities		3.61	%		3.53	%		3.04	%		2.3	%	18.8	%
Yield on money market instruments		3.81	%		4.09	%		4.44	%		(6.8)	%	(14.2)	%
Yield on interest earning assets		5.97	%		5.96	%		5.90	%		0.2	%	1.2	%
Cost of interest bearing deposits		1.68	%		1.70	%		1.74	%		(1.2)	%	(3.4)	%
Cost of borrowings		2.31	%		2.45	%		3.55	%		(5.7)	%	(34.9)	%
Cost of paying interest bearing liabilities		1.69	%		1.71	%		1.80	%		(1.2)	%	(6.1)	%
Net interest margin (g)		4.84	%		4.81	%		4.72	%		0.6	%	2.5	%
Efficiency ratio (g)		60.25	%		56.30	%		55.85	%		7.0	%	7.9	%
OTHER DATA (NON-GAAP) AND BALANCE SHEET INFORMATION:
Tangible book value per common share (d)	$	78.03		$	78.92		$	72.77			(1.1)	%	7.2	%
Average interest earning assets		11,620,536			11,664,671			9,388,308			(0.4)	%	23.8	%
Pre-tax, pre-provision net income (j)		69,837			77,437			62,128			(9.8)	%	12.4	%
Total assets under management/assets under administration – market value at period end		9,926,379			10,056,739			9,448,121			(1.3)	%	5.1	%
Note: Explanations for footnotes (a) – (k) are included at the end of the financial tables in the “Financial Reconciliations” section.
PARK NATIONAL CORPORATION
Financial Highlights (continued)
As of or for the three months ended September 30, 2026, June 30, 2026 and September 30, 2025
											Percent change 3Q ’26 vs.
(in thousands, except ratios)	September 30, 2026			June 30, 2026			September 30, 2025				2Q ’26		3Q ’25
BALANCE SHEET:
Investment securities	$	1,334,410		$	1,389,379		$	926,934			(4.0)	%	44.0	%
Loans		9,772,923			9,731,356			7,992,753			0.4	%	22.3	%
Allowance for credit losses		109,869			110,686			91,758			(0.7)	%	19.7	%
Goodwill and other intangible assets		303,382			300,986			162,237			0.8	%	87.0	%
Other real estate owned (OREO)		18,623			19,836			638			(6.1)	%	N.M.
Total assets		12,646,245			12,677,010			9,862,068			(0.2)	%	28.2	%
Total deposits		10,624,491			10,670,284			8,329,924			(0.4)	%	27.5	%
Borrowings		150,804			137,422			78,126			9.7	%	93.0	%
Total shareholders’ equity		1,712,960			1,726,576			1,331,821			(0.8)	%	28.6	%
Total equity		1,715,015			1,728,631			1,331,821			(0.8)	%	28.8	%
Tangible equity (d)		1,409,578			1,425,590			1,169,584			(1.1)	%	20.5	%
Total nonperforming loans		90,398			83,763			90,571			7.9	%	(0.2)	%
Total nonperforming assets		109,021			103,599			91,209			5.2	%	19.5	%
ASSET QUALITY RATIOS:
Loans as a % of period end total assets		77.28	%		76.76	%		81.05	%		0.7	%	(4.7)	%
Total nonperforming loans as a % of period end loans		0.92	%		0.86	%		1.13	%		7.0	%	(18.6)	%
Total nonperforming assets as a % of period end loans + OREO + other nonperforming assets		1.11	%		1.06	%		1.14	%		4.7	%	(2.6)	%
Allowance for credit losses as a % of period end loans		1.12	%		1.14	%		1.15	%		(1.8)	%	(2.6)	%
Net loan charge-offs	$	2,788		$	2,479		$	2,057			12.5	%	35.5	%
Annualized net loan charge-offs as a % of average loans (b)		0.11	%		0.10	%		0.10	%		10.0	%	10.0	%
CAPITAL & LIQUIDITY:
Total shareholders’ equity / Period end total assets		13.55	%		13.62	%		13.50	%		(0.5)	%	0.4	%
Tangible equity (d) / Tangible assets (f)		11.42	%		11.52	%		12.06	%		(0.9)	%	(5.3)	%
Average shareholders’ equity / Average assets (b)		13.71	%		13.46	%		12.88	%		1.9	%	6.4	%
Average shareholders’ equity / Average loans (b)		17.97	%		17.76	%		16.60	%		1.2	%	8.3	%
Average loans / Average deposits (b)		90.92	%		89.75	%		92.68	%		1.3	%	(1.9)	%
Note: Explanations for footnotes (a) – (k) are included at the end of the financial tables in the “Financial Reconciliations” section.

PARK NATIONAL CORPORATION
Financial Highlights
Nine months ended September 30, 2026 and September 30, 2025
		2026			2025
(in thousands, except common share and per common share data and ratios)	Nine months ended September 30			Nine months ended September 30				Percent change ’26 vs ’25
INCOME STATEMENT:
Net interest income	$	405,380		$	324,385			25.0	%
Provision for credit losses		6,283			7,639			(17.8) %
Other income		109,906			88,506			24.2	%
Other expense		313,663			236,604			32.6	%
Income before income taxes	$	195,340		$	168,648			15.8	%
Income taxes		37,969			31,214			21.6	%
Net income	$	157,371		$	137,434			14.5	%
MARKET DATA:
Earnings per common share – basic (a)	$	8.82		$	8.53			3.4	%
Earnings per common share – diluted (a)		8.77			8.48			3.4	%
Quarterly cash dividend declared per common share		3.30			3.21			2.8	%
Weighted average common shares – basic (b)		17,844,001			16,120,213			10.7	%
Weighted average common shares – diluted (b)		17,940,951			16,209,261			10.7	%
PERFORMANCE RATIOS: (annualized)
Return on average assets (a)(b)		1.69	%		1.82	%		(7.1) %
Return on average shareholders’ equity (a)(b)		12.48	%		14.21	%		(12.2) %
Yield on loans		6.40	%		6.32	%		1.3	%
Yield on investment securities		3.43	%		3.17	%		8.2	%
Yield on money market instruments		3.96	%		4.42	%		(10.4) %
Yield on interest earning assets		5.94	%		5.90	%		0.7	%
Cost of interest bearing deposits		1.67	%		1.74	%		(4.0) %
Cost of borrowings		2.29	%		3.82	%		(40.1) %
Cost of paying interest bearing liabilities		1.68	%		1.83	%		(8.2) %
Net interest margin (g)		4.82	%		4.70	%		2.6	%
Efficiency ratio (g)		60.51	%		57.03	%		6.1	%
ASSET QUALITY RATIOS:
Net loan charge-offs	$	7,895		$	3,847			105.2	%
Net loan charge-offs as a % of average loans (b)		0.11	%		0.07	%		57.1	%
CAPITAL & LIQUIDITY
Average shareholders’ equity / Average Assets (b)		13.52	%		12.78	%		5.8	%
Average shareholders’ equity / Average loans (b)		17.73	%		16.37	%		8.3	%
Average loans / Average deposits (b)		90.52	%		93.53	%		(3.2) %
OTHER DATA (NON-GAAP) AND BALANCE SHEET INFORMATION:
Average interest earning assets		11,334,593			9,284,221			22.1	%
Pre-tax, pre-provision net income (j)		201,623			176,287			14.4	%
Note: Explanations for footnotes (a) – (k) are included at the end of the financial tables in the “Financial Reconciliations” section.

PARK NATIONAL CORPORATION
Consolidated Statements of Income
		Three Months Ended							Nine Months Ended
		September 30							September 30
(in thousands, except share and per share data)			2026				2025			2026			2025
Interest income:
Interest and fees on loans		$	157,067			$	126,648		$	453,801		$	372,839
Interest on debt securities:
Taxable			9,394				5,644			24,558			19,467
Tax-exempt			2,508				1,520			6,857			4,292
Other interest income			4,885				5,140			15,742			11,050
Total interest income			173,854				138,952			500,958			407,648
Interest expense:
Interest on deposits:
Demand and savings deposits			23,627				20,499			67,993			57,990
Time deposits			8,586				5,501			25,240			18,092
Interest on borrowings			898				1,935			2,345			7,181
Total interest expense			33,111				27,935			95,578			83,263
Net interest income			140,743				111,017			405,380			324,385
(Recovery of) provision for credit losses			(964	)			4,030			6,283			7,639
Net interest income after (recovery of) provision for credit losses			141,707				106,987			399,097			316,746
Other income			36,638				30,574			109,906			88,506
Other expense			107,544				79,463			313,663			236,604
Income before income taxes			70,801				58,098			195,340			168,648
Income taxes			13,869				10,940			37,969			31,214
Net income		$	56,932			$	47,158		$	157,371		$	137,434
Per common share:
Net income – basic		$	3.15			$	2.93		$	8.82		$	8.53
Net income – diluted		$	3.13			$	2.92		$	8.77		$	8.48
Weighted average common shares – basic			18,064,161				16,071,347			17,844,001			16,120,213
Weighted average common shares – diluted			18,182,939				16,173,271			17,940,951			16,209,261
Cash dividends declared:
Quarterly dividend		$	1.10			$	1.07		$	3.30		$	3.21

PARK NATIONAL CORPORATION
Consolidated Balance Sheets
(in thousands, except share data)	September 30, 2026			December 31, 2025
Assets
Cash and due from banks	$	151,081		$	137,239
Money market instruments		388,390			96,274
Investment securities		1,334,410			802,142
Loans		9,772,923			8,051,242
Allowance for credit losses		(109,869	)		(92,973	)
Loans, net		9,663,054			7,958,269
Bank premises and equipment, net		100,358			61,627
Goodwill and other intangible assets		303,382			161,990
Other real estate owned		18,623			729
Other assets		686,947			586,743
Total assets	$	12,646,245		$	9,805,013
Liabilities and Equity
Deposits:
Noninterest bearing	$	3,054,899		$	2,656,093
Interest bearing		7,569,592			5,587,620
Total deposits		10,624,491			8,243,713
Borrowings		150,804			81,711
Other liabilities		155,935			126,796
Total liabilities	$	10,931,230		$	8,452,220
Equity:
Preferred shares (200,000 shares authorized; no shares outstanding at September 30, 2026 or December 31, 2025)	$	—		$	—
Common shares (No par value; 40,000,000 shares authorized at September 30, 2026 and December 31, 2025; 19,611,235 shares issued at September 30, 2026 and 17,623,104 at December 31, 2025)		786,942			465,032
Accumulated other comprehensive loss, net of taxes		(69,705	)		(12,739	)
Retained earnings		1,165,308			1,067,823
Treasury shares (1,547,074 shares at September 30, 2026 and 1,544,842 shares at December 31, 2025)		(169,585	)		(167,323	)
Total shareholders’ equity	$	1,712,960		$	1,352,793
Non-controlling interest in consolidated subsidiary		2,055			—
Total equity	$	1,715,015		$	1,352,793
Total liabilities and equity	$	12,646,245		$	9,805,013

PARK NATIONAL CORPORATION
Consolidated Average Balance Sheets
	Three Months Ended						Nine Months Ended
	September 30,						September 30,
(in thousands)		2026			2025			2026				2025
Assets
Cash and due from banks	$	149,028		$	123,603		$	176,496			$	121,804
Money market instruments		509,358			458,912			531,874				334,171
Investment securities		1,376,119			979,815			1,302,710				1,036,714
Loans		9,730,264			7,941,709			9,506,237				7,899,466
Allowance for credit losses		(111,619	)		(90,522	)		(108,937	)			(89,380	)
Loans, net		9,618,645			7,851,187			9,397,300				7,810,086
Bank premises and equipment, net		99,802			63,863			92,140				66,200
Goodwill and other intangible assets		301,740			162,400			283,634				162,666
Other real estate owned		20,137			651			19,054				536
Other assets		676,265			595,634			659,957				588,565
Total assets	$	12,751,094		$	10,236,065		$	12,463,165			$	10,120,742
Liabilities and Equity
Deposits:
Noninterest bearing	$	3,091,553		$	2,636,936		$	3,020,284			$	2,614,215
Interest bearing		7,609,925			5,931,591			7,481,895				5,831,973
Total deposits		10,701,478			8,568,527			10,502,179				8,446,188
Borrowings		153,917			216,140			136,879				251,299
Other liabilities		144,997			133,121			136,750				130,220
Total liabilities	$	11,000,392		$	8,917,788		$	10,775,808			$	8,827,707
Equity:
Preferred shares	$	—		$	—		$	—			$	—
Common shares		785,499			461,869			748,871				462,043
Accumulated other comprehensive loss, net of taxes		(24,549	)		(29,893	)		(16,590	)			(34,672	)
Retained earnings		1,157,282			1,054,373			1,120,830				1,024,908
Treasury shares		(169,585	)		(168,072	)		(167,576	)			(159,244	)
Total shareholders’ equity	$	1,748,647		$	1,318,277		$	1,685,535			$	1,293,035
Non-controlling interest in consolidated subsidiary		2,055			—			1,822				—
Total equity	$	1,750,702		$	1,318,277		$	1,687,357			$	1,293,035
Total liabilities and equity	$	12,751,094		$	10,236,065		$	12,463,165			$	10,120,742

PARK NATIONAL CORPORATION
Consolidated Statements of Income – Linked Quarters
		2026			2026		2026		2025		2025
(in thousands, except per share data)	3rd QTR			2nd QTR		1st QTR		4th QTR		3rd QTR
Interest income:
Interest and fees on loans	$	157,067		$	154,692	$	142,042	$	127,443	$	126,648
Interest on debt securities:
Taxable		9,394			9,320		5,844		4,267		5,644
Tax-exempt		2,508			2,123		2,226		1,487		1,520
Other interest income		4,885			6,192		4,665		3,695		5,140
Total interest income		173,854			172,327		154,777		136,892		138,952
Interest expense:
Interest on deposits:
Demand and savings deposits		23,627			23,517		20,849		18,431		20,499
Time deposits		8,586			9,122		7,532		5,267		5,501
Interest on borrowings		898			831		616		268		1,935
Total interest expense		33,111			33,470		28,997		23,966		27,935
Net interest income		140,743			138,857		125,780		112,926		111,017
(Recovery of) provision for credit losses		(964	)		4,575		2,672		3,849		4,030
Net interest income after (recovery of) provision for credit losses		141,707			134,282		123,108		109,077		106,987
Other income		36,638			39,540		33,728		31,375		30,574
Other expense		107,544			100,960		105,159		87,777		79,463
Income before income taxes		70,801			72,862		51,677		52,675		58,098
Income taxes		13,869			14,110		9,990		10,036		10,940
Net income	$	56,932		$	58,752	$	41,687	$	42,639	$	47,158
Per common share:
Net income – basic	$	3.15		$	3.25	$	2.40	$	2.65	$	2.93
Net income – diluted	$	3.13		$	3.23	$	2.39	$	2.63	$	2.92

PARK NATIONAL CORPORATION
Detail of other income and other expense – Linked Quarters
		2026		2026		2026		2025			2025
(in thousands)	3rd QTR		2nd QTR		1st QTR		4th QTR			3rd QTR
Other income:
Income from fiduciary activities	$	13,540	$	13,434	$	12,343	$	11,839		$	11,315
Service charges on deposit accounts		3,381		3,790		3,348		2,552			2,578
Other service income		4,318		4,124		3,686		4,099			3,716
Debit card fee income		8,257		8,107		6,973		6,493			6,604
Bank owned life insurance income		1,865		2,125		1,707		1,777			1,559
ATM fees		426		450		380		333			371
Gain (loss) on sale of debt securities, net		—		—		1,084		(2,250	)		—
Gain (loss) on equity securities, net		964		4,555		799		3,595			(549	)
Other components of net periodic benefit income		2,449		2,449		2,492		2,344			2,344
Miscellaneous		1,438		506		916		593			2,636
Total other income	$	36,638	$	39,540	$	33,728	$	31,375		$	30,574
Other expense:
Salaries	$	51,412	$	46,023	$	45,577	$	39,315		$	38,644
Employee benefits		12,614		11,918		11,692		10,846			9,892
Occupancy expense		4,338		4,027		4,572		3,349			3,242
Furniture and equipment expense		3,071		3,014		2,517		2,007			2,219
Data processing fees		14,406		15,113		13,141		12,188			11,531
Professional fees and services		9,171		8,731		16,828		9,275			7,475
Marketing		1,608		1,550		1,556		1,744			1,507
Insurance		2,007		1,986		2,074		1,534			1,468
Communication		1,663		1,400		1,425		1,137			1,239
State tax expense		1,504		1,529		1,367		1,181			1,182
Amortization of intangible assets		1,937		2,072		1,279		247			248
Foundation contributions		—		—		—		1,000			—
Miscellaneous		3,813		3,597		3,131		3,954			816
Total other expense	$	107,544	$	100,960	$	105,159	$	87,777		$	79,463

PARK NATIONAL CORPORATION
Asset Quality Information
											Year ended December 31,
(in thousands, except ratios)		September 30, 2026			June 30, 2026			March 31, 2026				2025			2024			2023			2022			2021
Allowance for credit losses:
Allowance for credit losses, beginning of period		$	110,686		$	108,590		$	92,973		$	87,966		$	83,745		$	85,379		$	83,197		$	85,675
Cumulative change in accounting principle; adoption of ASU 2022-02 in 2023 and ASU 2016-13 in 2021			—			—			—			—			—			383			—			6,090
First Citizens acquisition – Day 1 ACL			2,935			—			15,573			—			—			—			—			—
Charge-offs			4,675			4,470			4,440			16,624			18,334			10,863			9,133			5,093
Recoveries			1,887			1,991			1,812			10,143			8,012			5,942			6,758			8,441
Net charge-offs (recoveries)			2,788			2,479			2,628			6,481			10,322			4,921			2,375			(3,348	)
(Recovery of) provision for credit losses			(964	)		4,575			2,672			11,488			14,543			2,904			4,557			(11,916	)
Allowance for credit losses, end of period		$	109,869		$	110,686		$	108,590		$	92,973		$	87,966		$	83,745		$	85,379		$	83,197
General reserve trends:
Allowance for credit losses, end of period		$	109,869		$	110,686		$	108,590		$	92,973		$	87,966		$	83,745		$	85,379		$	83,197
Specific reserves on individually evaluated loans – certain accruing purchased credit deteriorated (“PCD”) loans			—			—			—			—			—			—			—			—
Specific reserves on individually evaluated loans – accrual			—			—			—			—			—			—			—			42
Specific reserves on individually evaluated loans – nonaccrual			5,119			4,424			3,041			739			1,299			4,983			3,566			1,574
General reserves on collectively evaluated loans		$	104,750		$	106,262		$	105,549		$	92,234		$	86,667		$	78,762		$	81,813		$	81,581
Total loans		$	9,772,923		$	9,731,356		$	9,667,260		$	8,051,242		$	7,817,128		$	7,476,221		$	7,141,891		$	6,871,122
Individually evaluated – certain accruing PCD loans (PCI loans for years 2020 and prior)			—			—			1,943			1,990			2,174			2,835			4,653			7,149
Individually evaluated loans – accrual (k)			8,800			11,535			14,792			18,365			15,290			—			11,477			17,517
Individually evaluated loans – nonaccrual			60,467			57,662			60,208			46,924			53,149			45,215			66,864			56,985
Collectively evaluated loans		$	9,703,656		$	9,662,159		$	9,590,317		$	7,983,963		$	7,746,515		$	7,428,171		$	7,058,897		$	6,789,471
Asset Quality Ratios:
Net charge-offs (recoveries) as a % of average loans (annualized)			0.11	%		0.10	%		0.12	%		0.08	%		0.14	%		0.07	%		0.03	%	(0.05)%
Allowance for credit losses as a % of period end loans			1.12	%		1.14	%		1.12	%		1.15	%		1.13	%		1.12	%		1.20	%		1.21	%
General reserve as a % of collectively evaluated loans			1.08	%		1.10	%		1.10	%		1.16	%		1.12	%		1.06	%		1.16	%		1.20	%
Nonperforming assets:
Nonaccrual loans		$	86,947		$	81,249		$	80,548		$	66,515		$	68,178		$	60,259		$	79,696		$	72,722
Accruing troubled debt restructurings (for years 2022 and prior) (k)		N.A.			N.A.			N.A.			N.A.			N.A.			N.A.				20,134			28,323
Loans past due 90 days or more			3,451			2,514			2,599			2,738			1,754			859			1,281			1,607
Total nonperforming loans		$	90,398		$	83,763		$	83,147		$	69,253		$	69,932		$	61,118		$	101,111		$	102,652
Other real estate owned			18,623			19,836			24,458			729			938			983			1,354			775
Other nonperforming assets			—			—			—			—			—			—			—			2,750
Total nonperforming assets		$	109,021		$	103,599		$	107,605		$	69,982		$	70,870		$	62,101		$	102,465		$	106,177
Percentage of nonaccrual loans to period end loans			0.89	%		0.83	%		0.83	%		0.83	%		0.87	%		0.81	%		1.12	%		1.06	%
Percentage of nonperforming loans to period end loans			0.92	%		0.86	%		0.86	%		0.86	%		0.89	%		0.82	%		1.42	%		1.49	%
Percentage of nonperforming assets to period end loans			1.12	%		1.06	%		1.11	%		0.87	%		0.91	%		0.83	%		1.43	%		1.55	%
Percentage of nonperforming assets to period end total assets			0.86	%		0.82	%		0.83	%		0.71	%		0.72	%		0.63	%		1.04	%		1.11	%
Note: Explanations for footnotes (a) – (k) are included at the end of the financial tables in the “Financial Reconciliations” section.
PARK NATIONAL CORPORATION
Asset Quality Information (continued)
											Year ended December 31,
(in thousands, except ratios)		September 30, 2026			June 30, 2026			March 31, 2026				2025			2024			2023			2022			2021
New nonaccrual loan information:
Nonaccrual loans, beginning of period		$	81,249		$	80,548		$	66,515		$	68,178		$	60,259		$	79,696		$	72,722		$	117,368
Acquired nonaccrual loans			—			—			4,506			—			—			—			—			—
New nonaccrual loans			25,218			21,099			23,215			87,482			65,535			48,280			64,918			38,478
Resolved nonaccrual loans			19,520			20,398			13,688			89,145			57,616			67,717			57,944			83,124
Nonaccrual loans, end of period		$	86,947		$	81,249		$	80,548		$	66,515		$	68,178		$	60,259		$	79,696		$	72,722
Individually evaluated nonaccrual commercial loan portfolio information (period end):
Unpaid principal balance		$	60,673		$	57,939		$	64,890		$	51,664		$	58,158		$	47,564		$	68,639		$	57,609
Prior charge-offs			206			277			4,682			4,740			5,009			2,349			1,775			624
Remaining principal balance			60,467			57,662			60,208			46,924			53,149			45,215			66,864			56,985
Specific reserves			5,119			4,424			3,041			739			1,299			4,983			3,566			1,574
Book value, after specific reserves		$	55,348		$	53,238		$	57,167		$	46,185		$	51,850		$	40,232		$	63,298		$	55,411
Note: Explanations for footnotes (a) – (k) are included at the end of the financial tables in the “Financial Reconciliations” section.

PARK NATIONAL CORPORATION
Financial Reconciliations
NON-GAAP RECONCILIATIONS
	THREE MONTHS ENDED									NINE MONTHS ENDED
(in thousands, except share and per share data)	September 30, 2026			June 30, 2026			September 30, 2025			September 30, 2026				September 30, 2025
Net interest income	$	140,743		$	138,857		$	111,017		$	405,380			$	324,385
less purchase accounting accretion		2,342			2,147			164			5,301				507
less interest income on former Vision Bank relationships		—			—			5			396				2,030
Net interest income – adjusted	$	138,401		$	136,710		$	110,848		$	399,683			$	321,848
(Recovery of) provision for credit losses	$	(964	)	$	4,575		$	4,030		$	6,283			$	7,639
less recoveries on former Vision Bank relationships		—			—			(3	)		(7	)			(1,817	)
(Recovery of) provision for credit losses – adjusted	$	(964	)	$	4,575		$	4,033		$	6,290			$	9,456
Other income	$	36,638		$	39,540		$	30,574		$	109,906			$	88,506
less gain on sale of debt securities, net		—			—			—			1,084				—
less impact of strategic initiatives		—			148			778			148				(118	)
less merger-related losses related to First Citizens acquisition		(295	)		—			—			(295	)			—
less Vision related OREO valuation adjustments, net		1,257			—			—			1,561				(229	)
less other income related to former Vision Bank relationships		—			—			325			(202	)			328
Other income – adjusted	$	35,676		$	39,392		$	29,471		$	107,610			$	88,525
Other expense	$	107,544		$	100,960		$	79,463		$	313,663			$	236,604
less intangible asset amortization		1,937			2,072			248			5,288				795
less merger-related expenses related to First Citizens acquisition		6,658			4,118			—			26,250				—
less impact of strategic initiatives		—			(71	)		—			291				—
less purchase accounting amortization		34			36			—			90				—
less direct expenses related to collection of payments on former Vision Bank loan relationships		130			—			—			324				515
Other expense – adjusted	$	98,785		$	94,805		$	79,215		$	281,420			$	235,294
Tax effect of adjustments to net income identified above (i)	$	1,146		$	811		$	(216	)	$	5,091			$	(635	)
Net income – reported	$	56,932		$	58,752		$	47,158		$	157,371			$	137,434
Net income – adjusted (h)	$	61,241		$	61,801		$	46,347		$	176,523			$	135,044
Diluted earnings per common share	$	3.13		$	3.23		$	2.92		$	8.77			$	8.48
Diluted earnings per common share, adjusted (h)	$	3.37		$	3.40		$	2.87		$	9.84			$	8.33
Annualized return on average assets (a)(b)		1.77	%		1.84	%		1.83	%		1.69	%			1.82	%
Annualized return on average assets, adjusted (a)(b)(h)		1.91	%		1.94	%		1.80	%		1.89	%			1.78	%
Annualized return on average tangible assets (a)(b)(e)		1.81	%		1.89	%		1.86	%		1.73	%			1.85	%
Annualized return on average tangible assets, adjusted (a)(b)(e)(h)		1.95	%		1.99	%		1.83	%		1.94	%			1.81	%
Annualized return on average shareholders’ equity (a)(b)		12.92	%		13.69	%		14.19	%		12.48	%			14.21	%
Annualized return on average shareholders’ equity, adjusted (a)(b)(h)		13.89	%		14.40	%		13.95	%		14.00	%			13.96	%
Annualized return on average tangible equity (a)(b)(c)		15.61	%		16.60	%		16.19	%		15.01	%			16.26	%
Annualized return on average tangible equity, adjusted (a)(b)(c)(h)		16.79	%		17.46	%		15.91	%		16.84	%			15.97	%
Efficiency ratio (g)		60.25	%		56.30	%		55.85	%		60.51	%			57.03	%
Efficiency ratio, adjusted (g)(h)		56.39	%		53.55	%		56.18	%		55.14	%			57.06	%
Annualized net interest margin (g)		4.84	%		4.81	%		4.72	%		4.82	%			4.70	%
Annualized net interest margin, adjusted (g)(h)		4.76	%		4.73	%		4.71	%		4.75	%			4.66	%
Note: Explanations for footnotes (a) – (k) are included at the end of the financial tables in the “Financial Reconciliations” section.

PARK NATIONAL CORPORATION
Financial Reconciliations (continued)
(a) Reported measure uses net income
(b) Averages are for the three months ended September 30, 2026, June 30,, 2026, and September 30, 2025 and the nine months ended September 30, 2026 and September 30, 2025, as appropriate
(c) Net income for each period divided by average tangible equity during the period. Average tangible equity equals average shareholders’ equity during the applicable period less average goodwill and other intangible assets during the applicable period.
RECONCILIATION OF AVERAGE SHAREHOLDERS’ EQUITY TO AVERAGE TANGIBLE EQUITY:
	THREE MONTHS ENDED							NINE MONTHS ENDED
	September 30, 2026			June 30, 2026		September 30, 2025		September 30, 2026			September 30, 2025
AVERAGE SHAREHOLDERS’ EQUITY	$	1,748,647		$	1,721,078	$	1,318,277	$	1,685,535		$	1,293,035
Less: Average goodwill and other intangible assets		301,740			301,545		162,400		283,634			162,666
AVERAGE TANGIBLE EQUITY	$	1,446,907		$	1,419,533	$	1,155,877	$	1,401,901		$	1,130,369
(d) Tangible equity divided by common shares outstanding at period end. Tangible equity equals total shareholders’ equity less goodwill and other intangible assets, in each case at the end of the period.
RECONCILIATION OF TOTAL SHAREHOLDERS’ EQUITY TO TANGIBLE EQUITY:
	September 30, 2026			June 30, 2026		September 30, 2025
TOTAL SHAREHOLDERS’ EQUITY	$	1,712,960		$	1,726,576	$	1,331,821
Less: Goodwill and other intangible assets		303,382			300,986		162,237
TANGIBLE EQUITY	$	1,409,578		$	1,425,590	$	1,169,584
(e) Net income for each period divided by average tangible assets during the period. Average tangible assets equal average assets less average goodwill and other intangible assets, in each case during the applicable period.
RECONCILIATION OF AVERAGE ASSETS TO AVERAGE TANGIBLE ASSETS
	THREE MONTHS ENDED							NINE MONTHS ENDED
	September 30, 2026			June 30, 2026		September 30, 2025		September 30, 2026			September 30, 2025
AVERAGE ASSETS	$	12,751,094		$	12,787,409	$	10,236,065	$	12,463,165		$	10,120,742
Less: Average goodwill and other intangible assets		301,740			301,545		162,400		283,634			162,666
AVERAGE TANGIBLE ASSETS	$	12,449,354		$	12,485,864	$	10,073,665	$	12,179,531		$	9,958,076
(f) Tangible equity divided by tangible assets. Tangible assets equal total assets less goodwill and other intangible assets, in each case at the end of the period.
RECONCILIATION OF TOTAL ASSETS TO TANGIBLE ASSETS:
	September 30, 2026			June 30, 2026		September 30, 2025
TOTAL ASSETS	$	12,646,245		$	12,677,010	$	9,862,068
Less: Goodwill and other intangible assets		303,382			300,986		162,237
TANGIBLE ASSETS	$	12,342,863		$	12,376,024	$	9,699,831
(g) Efficiency ratio is calculated by dividing total other expense by the sum of fully taxable equivalent net interest income and other income. Fully taxable equivalent net interest income reconciliation is shown assuming a 21% corporate federal income tax rate. Additionally, net interest margin is calculated on a fully taxable equivalent basis by dividing fully taxable equivalent net interest income by average interest earning assets, in each case during the applicable period.
RECONCILIATION OF FULLY TAXABLE EQUIVALENT NET INTEREST INCOME TO NET INTEREST INCOME
	THREE MONTHS ENDED							NINE MONTHS ENDED
	September 30, 2026			June 30, 2026		September 30, 2025		September 30, 2026			September 30, 2025
Interest income	$	173,854		$	172,327	$	138,952	$	500,958		$	407,648
Fully taxable equivalent adjustment		1,119			933		685		3,037			1,967
Fully taxable equivalent interest income	$	174,973		$	173,260	$	139,637	$	503,995		$	409,615
Interest expense		33,111			33,470		27,935		95,578			83,263
Fully taxable equivalent net interest income	$	141,862		$	139,790	$	111,702	$	408,417		$	326,352
(h) Adjustments to net income for each period presented are detailed in the non-GAAP reconciliations of net interest income, provision for credit losses, other income, other expense and tax effect of adjustments to net income.
(i) The tax effect of adjustments to net income was calculated assuming a 21% corporate federal income tax rate.
(j) Pre-tax, pre-provision (“PTPP”) net income is calculated as net income, plus income taxes, plus the provision for credit losses, in each case during the applicable period. PTPP net income is a common industry metric utilized in capital analysis and review. PTPP is used to assess the operating performance of Park while excluding the impact of the provision for credit losses.
RECONCILIATION OF PRE-TAX, PRE-PROVISION NET INCOME
	THREE MONTHS ENDED							NINE MONTHS ENDED
	September 30, 2026			June 30, 2026		September 30, 2025		September 30, 2026			September 30, 2025
Net income	$	56,932		$	58,752	$	47,158	$	157,371		$	137,434
Plus: Income taxes		13,869			14,110		10,940		37,969			31,214
Plus: (Recovery of) provision for credit losses		(964	)		4,575		4,030		6,283			7,639
Pre-tax, pre-provision net income	$	69,837		$	77,437	$	62,128	$	201,623		$	176,287
(k) Effective January 1, 2023, Park adopted Accounting Standards Update (“ASU”) 2022-02. Among other things, this ASU eliminated the concept of troubled debt restructurings (“TDRs”). As a result of the adoption of this ASU and elimination of the concept of TDRs, total nonperforming loans (“NPLs”) and total nonperforming assets (“NPAs”) each decreased by $20.1 million effective January 1, 2023. Additionally, as a result of the adoption of this ASU, accruing individually evaluated loans decreased by $11.5 million effective January 1, 2023.